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Abstract: 
 
Objective: The therapeutic alliance is possibly a crucial factor in 
treatment for borderline personality disorder (BPD). Among predictors 
of therapeutic alliance, aspects that have not yet been considered are 
metacognition or the patient’s capacity to be aware of mental states. We 
therefore explored whether metacognition predicted alliance and if 
metacognition and therapeutic alliance together predicted outcome in 
brief treatment for BPD. 
 
Method: In a secondary analysis of a randomized controlled trial, we 
included N = 36 patients with BPD in the current study. The original trial 
assessed the effects of a 10-session psychiatric standard treatment with 
or without the added the Plan Analysis and the Motive Oriented 
Therapeutic Relationship. We assessed the therapeutic alliance session 
by session (Working Alliance Inventory), metacognition at session 1 
(using the Metacognitive Assessment Scale-Revised) and outcome (using 
residual gains on the Outcome Questionnaire-45.2 between sessions 1 
and 10). 
 
Results: A more differentiated capacity to understand the mind of the 
others at treatment onset predicted an increase of therapist-rated 
alliance over time. Therapist rated alliance was the only significant 
outcome predictor (B = −0.85, R Squared = .12). 
 
Conclusions: More differentiated metacognition predicted therapeutic 
alliance which in turn affected outcome, thus making metacognition a 
relevant therapy target early in therapy for BPD. Future studies should 
expand this investigation to patients with better functioning, treated 
with different modalities and with longer treatments. 
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Psychotherapy Integration, Associate Editor of Psychology and Psychotherapy: 
Theory, Research and Practice, and, beginning in 2020, will be Editor-in-Chief  of 
the Journal of Clinical Psychology: In-Session. Pauline Maillard is a researcher at 
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HCPC-registered clinical psychologist. He is a Lecturer in Clinical Psychology 
and Postgraduate Research Director in the School of Health in Social Science, 
University of Edinburgh, Scotland. Ueli Kramer, PhD, is Privat- Docent, 
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Borderline Personality Disorder (BPD) is characterized by intense emotions, 
impulsivity and identity, and interpersonal problems. Psychotherapeutic 
options exist (Bateman & Fonagy, 2009; Linehan, 1993), but not all patients 
respond sufficiently, leaving room for the in-depth understanding of patient 
predictors for good process and outcome, in order to answer the question: 
what works for whom?  
One problem in treatments of BPD is an insufficient therapeutic alliance. A 
positive and sustained alliance has been linked with therapy outcome across 
treatment modalities and mental disorders (Flückiger, Del Re, Wampold, & 
Horvath, 2018; Horvath, Del, Flückiger,C, & Symonds, 2011). As regards BPD, 
the strength of therapeutic alliance was associated with treatment outcome 
and retention (Gunderson, Najavits, Sullivan, & Sabo, 1997; Hirsh, Quilty, 
Bagby, & McMain, 2012; Spinhoven, Giesen-Bloo, van Dyck, Kooiman, & 
Arntz, 2007). 
 
Yet, it remains unclear which patient predictors contribute to the  development  of 
the alliance, and which may hinder its development over treatment. Poor 
metacognitive capacities are one aspect that may impact the development of the 
therapeutic alliance and outcome in the beginning of treatment. Meta- cognition 
refers to the ability to recognize and reflect on mental states, both cognitions and 
affects of oneself and others, including the ability to use mentalistic knowledge for 
purposeful social problem solving (Carcione et al., 2010; Dimaggio & Lysaker, 
2010; Semerari et al., 2003; Semerari, Carcione, Dimaggio, Nicolò, & Procacci, 
2007). Metacognitive capacities include three broad functional domains: firstly, it 
involves self-reflection, which is the capacity to form increasingly complex ideas 
about the self (Lysaker  &  Dimaggio,  2014;  Semerari  et al., 2007). Higher order 
capacities include being able to recognize that our ideas do not necessarily mirror 
reality and to form an integrated view of oneself. Secondly, the under- standing of 
the others’  mind includes  the ability to recognize what others think and feel on 
the basis of overt cues and knowledge of contextual factors and personal history 
of the target. It also refers to the capacity to appraise the others’ perspective as 
different from our own (Semerari et al., 2007). Thirdly, the mastery domain 
involves the capacity to solve relational problems and soothe psychological pain 
on the basis of increasingly complex awareness of mental states and using 
adaptive strategies that are fed with mentalistic knowledge (Carcione et al., 
2011). Such a detailed differentiation of the concept of metacognitive capacity is 
needed, as it was reported that global scores of metacognition  miss the 
assessment of clinically relevant, and more precise, variety of lower- order 
functions (Semerari et al., 2005). 
 
 
Patients presenting with severe mental conditions appear to have 
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impairments in several lower-order functions of metacognitive capacity 
(Maillard et  al.,  2017;  Pellecchia et al., 2017; Semerari et al., 2005, 2014, 
2015). They have also serious difficulties in using knowledge about mental 
states for purposeful problem solving (Carcione et al., 2011; Lysaker et al., 
2014). In the context of therapy collaboration, it may be assumed that the 
quality of the patient’s capacity of thinking about other’s mental states (i.e., the 
second sub- function outlined above) impacts the level of the therapeutic 
alliance. Knowledge about the differential role the different types of 
metacognitive capacities play for alliance formation may help clinicians be 
more attentive to specific mentalistic operations early in treatment and adapt 
the treatment accordingly. 
 
Predicting the Therapeutic Alliance in Psychotherapy 
 
Research on predictors of the therapeutic alliance (i.e., both static and dynamic 
operationalizations) by intake features in treatments for BPD has been scarce, 
so far. More broadly for any mental condition, we divide predictors into 
therapist-related, relational and patient-related. As regards therapist-related 
factors, theoretical background, expertise, and personal characteristics seem 
important, for example it was shown that therapists with higher facilitative 
interpersonal skills achieved better client-rated alliance and better outcomes 
(Anderson, Crowley, Himawan, Holmberg, & Uhlin, 2016). Therapists’ 
attachment predicts the quality of the therapeutic relationship, whereas 
therapist’s immediacy has an overall positive effect on the quality of the 
therapy relationship, as perceived by the patient (Shafran, Kivlighan, Gelso, 
Bhatia, & Hill, 2016; Steel, Macdonald, & Schroder, 2017). Depth of 
interpretations in psychodynamic therapists negatively influenced patients’ 
perception of the alliance (Petraglia, Bhatia, De Roten, Despland, & Drapeau, 
2015). Relational factors may influence the alliance; a crucial aspect may be the 
presence of in- session corrective relational experiences, which were linked 
with a higher patient-rated alliance, compared to those patients that did not 
present corrective experiences (Huang, Hill, Strauss, Heyman, & Hussain, 
2016). 
 
Patient factors may influence the alliance. The capacity to experience affects in 
session was linked to a better therapeutic alliance in the following session in 
patients with depression (Town, Salvadori, Falkenström, Bradley, & Hardy, 2017). 
Attachment type was related with the therapeutic alliance across a number of 
studies (Bernecker, Levy, & Ellison, 2014). The number of criteria on narcissistic, 
borderline, histrionic and antisocial personality disorders predicted alliance in a 
residential treatment for clients with substance abuse (Outcalt et al., 2016). 
Outcome expectation is a central predictor of the therapeutic alliance with 
demonstrated bidirectional influences between alliance and expectation in a 
sample with depression (Vîslă, Constantino, Newkirk, Ogrodniczuk, & Söchting, 
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2016). The way patients presented themselves influenced therapist-rated alliance, 
with persons tending to set agenda, and self-promotion being more positively 
rated, while persons tending to supplicate elicited more negative reactions. 
Patients’ views slightly differed,  and setting  agenda   had   a negative impact on 
their perception of the alliance, while self-promotion had a positive impact 
(Frühauf, Figlioli, Böck, & Caspar, 2015). 
Among patient’s factors, there is evidence pointing to the observation that 
metacognitive capacities affect the therapeutic alliance. A patient who 
presents with more differentiated metacognitive capacities is more likely 
to cognitively construe the person of the therapist and the therapeutic 
interaction in a nuanced and at least in a slightly positive and welcoming 
way. Such metacognitive readiness for   positive    alliance   may    result    
in a warmer and more solid interpersonal bond   with   the    therapist.    
Indirectly, a therapist facing a patient with preserved metacognitive 
capacities may feel more accepted, welcoming, effective and is less likely 
to have to work through negative countertransference. Reflective 
functioning, a measure of the construct of mentalizing (Fonagy, Target, 
Steele, & Steele, 1998), which shares with metacognition the focus on 
capacity to understand and regulate mental states, predicted lower 
therapist-rated alliance in treatment of depression and depression-
specific reflective functioning predicted lower patient- rated alliance 
(Ekeblad, Falkenström, & Holmqvist, 2016). Similarly, in cognitive- 
behavior therapy for depression, poor awareness of affects had a negative 
effect on depression improvement: this link was mediated by patient-
rated alliance (Quilty et al., 2017). Poor affect awareness tended to 
predict poor treatment response in group therapy for BPD (Ogrodniczuk, 
Piper, & Joyce, 2011), though more recent   studies   did   not    display   
such a negative effect (Joyce, Fujiwara, Cristall, Ruddy, & Ogrodniczuk, 
2013). Locati, Rossi, and Parolin (2017) found that metacognition, 
therapeutic alliance and therapy technique interacted with each another 
in early therapy stages. Metacognition mediated the relationship between 
the type of intervention and the therapeutic alliance in moments where 
collaboration among patient and therapist was positive; this effect 
vanished in the case of a rupture in the therapeutic alliance. 
 
Fostering the Therapeutic Alliance in Borderline Personality Disorder 
Treatment Using Individualized Case Formulations 
 
Predictor research into the alliance points to the necessity of understanding 
the patient’s intake features in detail, as they are assessed by the therapist 
or the researcher. Case formulation may help in this task. In a controlled 
study, Kramer et al. (2014) randomized patients with BPD to two conditions: 
a) a standard brief treatment based on psychiatric principles (Gunderson & 
Links, 2014) and b) the same treatment augmented with an individualized 
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case formulation according to the principles of Plan Analysis (Caspar, 2007). 
Using such a case formulation favors the appropriate use of the patient’s 
process characteristics, by focusing the intervention on the underlying 
motives (i.e., motive-oriented therapeutic relationship; Caspar, 2007). 
Results of the study indicated that whereas both conditions produced 
comparable reductions in borderline symptoms, the patients receiving the  
individualized  treatment  evolved  in   a slightly more positive way in general 
symptoms. In terms of the therapeutic alliance, there were no between-
condition differences for the patient’s view of the dynamic evolution of the 
therapeutic alliance, but the therapist in the individualized condition rated 
the alliance more positively over time (Kramer, Flückiger, et al., 2014). This 
study showed the relevance of an individualized treatment component for 
process and outcome in the very beginning of therapy for BPD. It was argued 
that such treatment individualization may moderate the predictive link 
between metacognitive capacities and therapeutic alliance, and outcome 
(Kramer & Stiles, 2015). 
 
Hypotheses 
 
In light of reviewed evidence, we investigated the relationships among 
metacognition, alliance, and outcome in a randomized con- trolled trial for 
BPD. We hypothesized that metacognitive capacities at intake impact alliance 
and outcome in the following ways: 1) the higher the metacognitive capacities 
(related with the understanding of the other’s mind) at intake, the higher the 
therapeutic alliance, from both patient’s and therapist’s perspectives; 2) the 
higher the metacognitive capacities (related with the understanding of the 
other’s mind) at intake, the greater the dynamic increase in the therapeutic 
alliance session-by-session progression, from both patient’s and therapist’s 
perspectives; 3) individualization of treatment was a moderator of the link 
between metacognition and the therapeutic alliance. 
 
METHOD 
 
Design 
The present process-outcome study builds on the outcome study by Kramer et 
al. (2014) on individualizing brief treatment for patients with BPD, and the 
process-outcome mediation analysis by Kramer, Keller, Caspar, de Roten, and 
Despland (2017) on a sub- sample of N = 57 patients with borderline personality 
disorder (BPD). In the original study, the patients were randomized to either 10 
weekly sessions of brief psychiatric treatment alone (Good Psychiatric 
Management, GPM; Gunderson & Links, 2014) or to 10 weekly sessions of brief 
psychiatric treatment with the motive-oriented therapeutic relation- ship 
component (MOTR; i.e., the individualized or responsive treatment; Caspar, 
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2007). The research protocol was approved by the local ethics board (clearance 
number 254/ 08), as well as the research committee of the university 
department. 
 
Participants 
 
Patients 
Out of the N = 57 patients from the previous process-outcome study, we retained 
N = 36 patients for the present in-depth analysis of metacognition and the 
alliance over time. We excluded n= 18 patients with an intake session involving 
structured assessments (i.e., diagnostic, suicidal or addiction) which may be 
clinically meaningful, but is unsuitable for process coding of metacognition, n = 1 
patient being treated with translator, n = 1 patient with head injury potentially 
affecting the process coding, as well as n = 1 patient with missing alliance data (N 
= 36 in total in the sample). Out of these, 16 were attributed to the GPM condition 
and 20 to the GPM + MOTR condition. At baseline, the two conditions did not 
differ in terms of age (t(1, 34) = −0.68, p = .50),  gender (χ2 (1) = 1.89, p = .17), 
employment (χ2 (1) = 3.55, p = .31), number of BPD criteria (t(1, 34) = −0.32, p = 
.75), number   of diagnoses on axis I (t(1, 34) = −0.07, p = .91) and II (t(1, 34) = 
0.27, p = .79), Global Assessment of Functioning (t(1, 34) = −1.62, p = .11), level 
of OQ-45 symptoms (t(1, 34) = −1.04, p = .31) and level of metacognition at 
intake (t(1, 34) = 1.68, p =.10). However, the two conditions differed in terms 
of marital status (χ2 (1) = 8.80, p = .01), patients from the GPM + MOTR 
condition being more frequently married than in the GPM one. Psychiatric 
diagnoses were assessed by trained clinicians with the Mini International 
Neuropsychiatric Interview (Lecrubier et al., 1997) for DSM-IV axis I and the 
SCID-II (First & Gibbons, 2004) for DSM- IV axis II. On average, patients had 
7.08 (SD = 1.5) BPD criteria. 
 
Therapists 
Ten therapists were in charge of the GPM-based treatment: one therapist 
treated four patients, one therapist treated two patients, one therapist treated 
three patients, and seven therapists treated one patient. For the GPM + MOTR 
condition, a total of five therapists were in charge of the patients: one therapist 
treated eight patients, one therapist treated six patients, one therapist treated 
three patients, one therapist treated two patients, and one therapist treated one 
patient. They were six psychiatrists and six psychologists with at least 1 year of 
psychiatry residency and a basic psychodynamic background. Three therapists 
were nurses. 
Treatments 
 
GPM Condition. Ten weekly sessions of psychiatric treatment for BPD were 
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offered to the patients (Good Psychiatric Management; GPM; Gunderson & 
Links, 2014); when needed more treatment was offered  to the patients 
(Kramer et al., 2017), in the sense of a stepped care approach for BPD. A 
specific manual rendered explicit the adaptation of the principles of GPM 
treatment to a 3-month brief treatment (Charbon et al., 2019). The 3-month 
treatment had the following contents: communication about psychiatric 
diagnoses, comorbidities and psychiatric anamnesis, definition of the 
principal problems and treatment target, identification of short-term 
objectives, recognition of and dealing with difficulties interfering with the 
treatment and finally formulation of the relational interpretations of core 
conflictual themes. 
 
MOTR Condition. The MOTR condition is the same as the GPM condition, with 
the additional implementation of an idiographic case formulation following 
the principles of Plan Analysis and the motive-oriented therapeutic 
relationship (MOTR; Caspar, 2007), aiming at the individualizing of the initial 
10 sessions. Treatment adherence was assessed cross-sectionally for both 
treatment conditions for both treatment concepts. As expected, both conditions 
presented with high-level adherence to GPM principles (non-significant 
difference, Kramer, Kolly, et al., 2014) and the MOTR condition out- 
performed the GPM condition with regard to adherence to the individualized 
motive- oriented therapeutic relationship (t (1, 59)= 10.62; p<  .00+) 
 
Instruments 
 
Working Alliance Inventory – Short Form (Tracey & Kokotovic, 1989). We used 
the French version (Corbière, Bisson, Lauzon, & Ricard, 2006) of this 12-item 
self-report questionnaire. It aimed at asses- sing patient – (WAI-P) and 
therapist-rated (WAI-T) alliance on a 1 (never) to 7 (always) Likert-type scale. 
Questionnaires were completed after each therapy session. Internal 
consistency was excellent (α = .90–.96). 
 
Outcome Questionnaire-45.2 (OQ- 45; Lambert et al., 2004) is a self-report 
questionnaire designed for assessing three domains of mental health 
functioning and their change due to treatment: symptom dis- tress, 
interpersonal functioning, and social role. Items are assessed on a 4-point 
Likert scale, ranging from 1 (never) to 4 (always). A global score and scores 
for each subscale are computed. The OQ-45 has been translated and validated 
in  French  (Lambert  et al., 1996). It was given after first and penultimate 
sessions. Cronbach’s alpha was α = 0.94. 
 
Metacognition Assessment Scale- Revised (MAS-R; Carcione et al., 2010) is  an 
observer-rating scale that provides an assessment of metacognitive abilities and 
their changes in individuals’ narratives. The MAS-R provides a global score as 
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well as a score for three metacognitive domains and their subfunctions: 
 
1. Understanding of one’s own Mind (UM  subscale)  is   the   ability   of a 
person to understand his own mental states. The three subfunctions of 
UM are: 1) the Monitoring, which is the recognition and description of 
cognitions and emotions as well as their links with behaviors; 2) the 
Differentiation or the ability to make the difference between fantasies 
or beliefs and reality; 3) the Integration, which is the ability to construct 
a unified view of the self. 
2. Understanding of Other’s Mind (UOM subscale) is the ability to 
understand others’ mental states. It includes 1) the Monitoring, which 
is the recognition and description of others’ cognitions, emotions and 
their links between them and others’ behaviors and 2) the 
Decentration, or the ability to put oneself in others’ shoes and make 
hypotheses about others’ mental states which are independent from 
one’s own perspective. 
3. Mastery (M subscale) is the capacity  to use mentalistic knowledge and  
adopt an active attitude in order to cope with suffering and solve conflicts. 
Three  different   levels   exist,   from   a more behavioral to a more 
metarepresentative level. 
 
All   subfunctions are  rated on a 5-points Likert scale ranging from 1 = “scarce” 
(sporadic, poorly articulated, not spontaneous, probing does not generate 
improvement) to 5 = “sophisticated” (sustained talk about mental states, 
description are rich, talk of mental states is spontaneous or  there  is  an  
autonomous  elaboration  of a question/suggestion). The rating scale  gives also 
the possibility to score “not engaged” when a subfunction does  not appear in 
the transcript. 
Procedure 
 
MAS-R Assessment and Rating 
Once the outcome study completed, the video-recorded  intake  sessions  of  the  
N = 36 patients were transcribed word by word (Mergenthaler & Stigler, 1997). 
MAS- R ratings were done based on the transcripts. Each transcript was split 
into inter- action units. Each interaction unit represents one intervention of 
the therapist and one intervention of the patient (patient/therapist ratings). 
The total number of interaction units was then divided by three in order to 
obtain three scoring units for each transcript. This way of doing is first of all 
practical because the scoring of the entire transcript would imply  to  keep  in  
mind  a huge amount of information and could therefore prejudice the 
psychometric proper- ties of the scale. Moreover, metacognition is supposed 
to evolve, to change depending on the topic for example. Accordingly, the sub- 
division in scoring units allows a more precise knowledge about the level of 
11  
metacognition in each part of the session. 
 
Two independent raters, the  first and   the   second   authors,   along   with 
a Master’s degree student, scored each scoring unit. First author is one of 
the creators of the MAS-R and second author is a psychologist with a 5-year 
experience in clinical and research settings who was trained for 6 months in 
the MAS-R scoring of three Adult Attachment Interviews and seven 
therapeutic sessions (different from those used for the present  study). All 
scorers were blind to any information concerning   participants  or  sessions.  
A consensus score was used for the data collection. 
 
Statistical Analyses 
 
For the preliminary analyses, inter-rater reliability analysis was conducted using 
Intra- Class Coefficients (Shrout & Fleiss, 1979) on 20% of the ratings. In order to 
establish outcome indexes, a Paired sample t –test, and an ANCOVA (between-
condition comparison, controlling for symptom level at intake) were conducted. 
Given the differences between conditions, as defined by design, condition was 
always introduced as moderator in the analyses (not just on the level of 
hypothesis 3). The first hypothesis designating the impact of MAS-R on the mean 
WAI (P and T) was tested using a single regression model for each of the averaged 
(over time) WAI-perspectives (P and T). Even though the hypothesis concerns the 
MAS-R subscale of understanding of other’s mind (UOM), the other subscales are 
tested for discriminant predictive validity purposes. The second hypothesis 
assumed that MAS-R had an impact on the alliance progression over the course of 
therapy. In order to test this hypothesis, we conducted two parallel (for each WAI-
perspective as dependent variable) Hierarchical Linear Models (HLM; Bryk & 
Raudenbush, 1987) with the following coefficients (on level 1 were the sessions, 
on level 2 the patients (Level 1: γij = β0j*(session) + β1j + ε; Level 2: β0j= γ00 + μ0j; β1j 
= γ10 + γ11* (MAS-R) + γ12*(condition) + u1j)). In order to control for therapist 
effects known to be of importance, we introduced a third level on which 
therapist’s effects were modeled: γ00= π00 + r00; γ10= π10 + r10; γ11= π11 + r11. The 
third hypothesis formulated a link between the process variables (MAS-R and 
WAI) and outcome, with a particular focus on the moderating effect of the 
condition (standard vs individualized). In order to test this hypothesis, we used a 
regression model (method remove) with the most significant (static and 
dynamic) predictors from the earlier analyses. The method remove is particularly 
performant in defining a parsimonious model, by maximizing the explained 
variance by the model. 
RESULTS 
 
Preliminary Analyses 
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MAS-R scoring’s inter-reliability was calculated  for  20%  of  the transcripts  (N 
= 15) with Intra-Class Coefficients (ICC). It was  sufficient,  with  a  mean  ICC  
(2,  1)  =.81 (SD = .17, range = .65 - .96). Both conditions taken together showed 
a significant pre-post  decrease in symptoms (OQ-45:  t(1, 35)   =   4.16,   p   =   
.00+).  We  also found a marginal outcome advantage favoring GPM + MOTR, 
compared with the standard condition, when controlling for symptom level 
at intake (F(1, 35) = 4.05, p = .05). These results were not affected by the 
patient’s marital status (which differed between the conditions). 
 
Does Metacognition Affect the Alliance Average and Progression? 
There was no significant predictive link between MAS total at intake and both 
alliance mean scores. MAS total predicted only 1% of the variance of the 
patient’s mean alliance (F(1, 35) = 0.09; p = .92) and only 5% of the variance 
of the therapist’s mean alliance (F(1, 35) = 0.96; p = .39). This result was 
consistent across the three sub-scales, for both rating perspectives, and 
remained unaffected by the patient’s marital status. Condition did not 
moderate this link. 
 
When explaining the alliance progression over the course of the first 10 sessions 
of therapy, we found that for the patient’s perspective, metacognitive abilities at 
intake did not affect the alliance progression. This was consistent for all sub-
scales of MAS-R and was independent from the treatment condition (Table 1). 
However, for the therapist’s perspective, the averaged sub- scale 
Understanding the Other’s Mind (UOM) at intake did affect alliance 
progression (Table 2). The higher the scores on the UOM, the steeper the slope 
of the increase in the therapist’s coded therapeutic alliance over time. This 
result remained unaffected by treatment condition nor therapist effects 
modeled on level 3 of the HLM. 
 
Predicting Therapeutic Outcome with Metacognition, Therapeutic Alliance 
and Treatment Condition 
 
Given the central role of the therapeutic alliance coded by the therapist in 
the dynamics of the impact of the MAS, we   focused    our    final    analyses    
on a comparison between the predictive power of patient’s vs therapist’s 
coded alliance, together with MAS and condition as moderator, for distal 
outcome (symptom change after session 10). The linear regression models, 
method removal, included both static (mean alliance) and dynamic 
(alliance slope) predictors of out- come. Firstly, we found that the dynamic 
predictors did not affect outcome significant, but the static did. Secondly, 
we were able to confirm that the mean of the therapist’s coded alliance, was 
the only significant variable explaining significantly outcome variance (12% of 
the variance; Table 3). We re-ran these models with the patient’s  marital  
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status,  yielding a consistent picture. 
 
DISCUSSION 
 
The therapeutic alliance may be an important factor for any treatment, and in 
particular for patients with BPD (McMain, Boritz, & Leybman, 2015). It is 
therefore critical to understand central predictors of alliance formation over 
time. We hypothesized that the capacity to understand other’s mental states on 
the basis of mentalistic awareness, i.e.  metacognition  (Semerari  et al., 2003) 
contributes both to the therapeutic alliance and outcome, in line with previous 
evidence (Locati et al., 2017). This study examined whether metacognitive 
understanding of other’s mind at intake predicted therapeutic alliance, 
measured both from the patient’s and the therapist’s perspective, and both 
static and dynamic measurements of the alliance. We also examined whether 
the individualization of intervention contributed as moderator to this model. 
 
Our first two hypotheses were that baseline understanding of other’s mind was 
linked with therapeutic alliance. The idea was that patients with higher 
understanding of the others may be quicker in taking the therapist’s 
perspective and constructively use therapist’s observations. Whereas neither 
patients’ nor therapists’ average assessments of the level of alliance were 
connected to understanding of other’s mind at treatment onset, we found a link 
between metacognitive understanding of other’s mind at treatment onset and 
the dynamic operationalization of the therapeutic alliance. Therapists assessed 
the alliance increasingly positively facing patients who had a more developed 
aware- ness of the mind of the others. One may hypothesize that the patient’s 
manifest capacity to reflect on others (UOM) made the therapist more hopeful 
or optimistic in terms of his/her assessment of the cooperation; the therapist 
may also be more and more hopeful with regard to a positive evolution and 
outcome of patients with more pre- served capacities of reflection on others. 
Conversely, facing patients who lack capacities to understand others, results 
suggest that the therapists may appraise them as non- cooperative, hostile or 
they may feel frustrated or even to some extent useless (Dimaggio, Semerari, 
Carcione, Nicolò, & Procacci, 2007). 
 
Patient assessments of the alliance, both static and dynamic, remained unaffected 
by understanding of other’s mind. An absence of link between the patient’s 
capacity to reflect on others (and the self) and his/her cooperative stance in 
therapy may be due to the fact that early in treatment, patients with BPD may 
either underestimate or overestimate the quality of the cooperation and the 
possible gains which may be obtained through the therapy sessions. This may 
influence their assessment of the alliance. Levy, Beeney, Wasserman, and Clarkin 
(2010) discussed that the global measurement of the patient’s self-reported 
therapeutic alliance  
14  
 
may ignore the more subtle moment-by-moment state fluctuations 
characteristic of patients with BPD in variables relevant to both cooperation 
(i.e., therapeutic alliance) and mentalistic abilities. We may also speculate that the 
treatment was too short, in order for the patient’s capacities to affect the mean 
and the progress of the therapeutic alliance in BPD. There is a chance in fact that 
with needed time, patients whose self- reflective capacities and mastery grow 
more will be more capable to use them in order to buffer their own negative 
perception of alliance and therefore become increasingly cooperative, which 
may eventually lead to better outcomes (Semerari et al., 2007). 
 
Finally, we may explain this absence of link with the rather severe clinical 
presentations of the patients in this study. It is possible that the alliance was 
affected by variables other than metacognition, the latter being overridden by 
the influence of third variables, e.g., emotion dysregulation, capacity to 
experience affects in session (Town et al., 2017) and patients’ attachment pat- 
terns (Bernecker et al., 2014). Results there- fore need replication in other 
samples, possibly with more preserved socio- economic status and higher 
functioning measuring other variables which possible influence the link 
between alliance and out- come. 
The observation that no other metacognitive ability functioned as predictor in 
the present study speaks to the discriminant predictive validity of the specific 
sub-scales of the MAS-R. Concepts measured by the MAS-R sub-scales UM 
(Understanding own’s mind) and M (Mastery) did not affect the therapeutic 
alliance in this specific manner. At least from a predictive validity perspective 
for the therapeutic alliance, the differentiation of mentalis- tic capacities in 
lower-level functional domains, rather than the use of an aggregated global 
score, seems promising and should be taken into account in further studies. 
 
Our third hypothesis assumed that therapeutic alliance and metacognition, 
moderated by condition, predicted outcome. We assumed that higher 
metacognitive abilities, together with a productive alliance and individualizing 
treatment contributed to symptom reduction. Results did not support a 
moderating role of the individualizing condition. They only supported the 
predictive role of therapist alliance on outcome; meta- cognitive capacities fell 
short of remaining in the most parsimonious model. 
 
The observation that the individualization of the intervention, here in the form of 
the motive-oriented therapeutic relationship, did not result in any moderating 
effect in the context of the present study worth discussing. Individualizing 
treatment affects therapy process and outcome only under certain circum- stances. 
When looking at links between metacognitive intake predictors and the 
therapeutic alliance, both variables with strong predictive validity, the potential 
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effects of individualizing may have been  overridden  by these variables. More 
research is needed in this domain, both using larger samples in the context of 
randomized controlled methodology for patients with BPD, and using qualitative 
descriptions of the process of change in these treatments (Kramer, 2019). Also, it 
has to be explored whether a moderating effect of treatment condition on the link 
between alliance and outcome is found in therapies specifically tailored to address 
poor mentalistic capacities (e.g., Bateman & Fonagy, 2004; Dimaggio, Montano, 
Popolo, & Salvatore, 2015; Dimaggio et al., 2007). 
 
Taken together, our results may be interpreted as preliminary   evidence for  a 
sequential model explaining the dynamics of how initial symptom relief is 
produced in patients with BPD. Intake features of patients with BPD, such as 
their capacity to reflect on other’s mind, may not directly affect initial symptom 
relief over the first few sessions of therapy, but these features may be mediated 
by the level of the therapeutic alliance, as rated by the therapist. Such a model 
may speak to the important role the therapist perception of collaboration plays 
in the first few sessions of therapy facing a patient with BPD: he/she will have to 
be able to face patient- related negative aspects such as hostility and be able to 
prevent ruptures or readily repair them (Eubanks, Muran, & Safran, 2018; 
Wolf, Goldfried, & Muran, 2017). 
 
Clinical implications of a sequential understanding of change in brief treatments 
may be found on the level of psychotherapy training. Firstly, therapist receiving 
training which helps them identify correctly patient’s capacities of understanding 
the other’s mind may be able to construe more productive therapeutic 
collaboration. Secondly, treating patients with BPD, especially severe forms, may 
elicit many forms of negative counter- transferential reaction in the therapist (Colli, 
Tanzilli, Dimaggio, & Lingiardi, 2014; Searles, 1988) which range from anger to self- 
criticism, guilt, anxiety, worry, overwhelming, overinvolvement, pessimism and 
frustration, leading therapists to losing motivation to retain the patient in therapy 
(Cleary, Siegfried, & Walter, 2002; McMain et al., 2015). 
 
This study has limitations. For one, our sample involved rather poorly 
functioning individuals. Therefore, we need to be cautious about generalization 
to higher functioning samples and different cultural contexts. More- over, the 
treatment delivered is brief, calling for replication within longer treatments. 
Variables not measured here may have had an impact on the process and 
outcome, such as attachment history, maladaptive interpersonal schemas, affect 
expression and emotional dys- regulation. Future studies need to assess these 
variables in order to form an increasingly accurate picture of the therapy 
process. 
 
Overall, our results speak for the importance of assessing metacognition early 
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in therapy, as its impairment is likely to affect the way the therapist appraises 
the therapeutic alliance. Mindful of problems in metacognition, therapist may 
swiftly adapt their interventions, thus buffering its impact and possibly 
increasing chances of therapy success. 
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Table 1: Patient’s alliance progression as predicted by baseline metacognitive capacity 
(HLM; N = 36) 
Variable Coefficient robust SE t (33) p 
Total MAS 
   Condition 
Mean UM 
   Condition 
Mean UOM 
   Condition 
Mean M 
   Condition 
-1.89 
2.79 
-1.97 
2.57 
-0.94 
3.00 
-1.32 
3.14 
3.43 
3.91 
3.29 
3.94 
3.29 
3.89 
3.04 
3.74 
-0.55 
0.71 
-0.60 
0.65 
-0.29 
0.77 
-0.43 
0.84 
.59 
.48 
.55 
.52 
.77 
.45 
.67 
.41 
Note. HLM: Hierarchical Linear Modeling; MAS: Metacognition Assessment Scale; UM: 
Understanding of one’s Own Mind; UOM: Understanding of Others’ Minds; M: Mastery; 
Condition: Standard General Psychiatric Management vs Individualized (using the 
Motive-Oriented Therapeutic Relationship Component) General Psychiatric 
Management. 
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Table 2: Therapist’s alliance progression as predicted by baseline metacognitive capacity 
(HLM; N = 36) 
Variable Coefficient robust SE t (33) p 
Total MAS 
   Condition 
Mean UM 
   Condition 
Mean UOM 
   Condition 
Mean M 
   Condition 
2.40 
0.13 
0.22 
-0.23 
5.62 
0.83 
3.01 
-0.22 
3.01 
2.76 
2.56 
2.73 
2.90 
2.75 
2.64 
2.55 
0.80 
0.05 
0.09 
-0.09 
1.94 
0.30 
1.14 
-0.09 
.43 
.96 
.93 
.93 
.04 
.77 
.26 
.93 
Note. HLM: Hierarchical Linear Modeling; MAS: Metacognition Assessment Scale; UM: 
Understanding of one’s Own Mind; UOM: Understanding of Others’ Minds; M: Mastery; 
Condition: Standard General Psychiatric Management vs Individualized (using the 
Motive-Oriented Therapeutic Relationship Component) General Psychiatric 
Management. 
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Table 3: Predicting symptom change at session 10 with condition, mean alliance and 
baseline metacognitive capacity (N = 36) 
Variables R2 B SE β t p 
Model 1 
  Condition 
  Total MAS 
  WAI Patient 
  WAI Therapist 
Model 2 
  Condition 
  Total MAS 
  WAI Therapist 
Model 3 
  WAI Therapist 
.28 
 
 
 
 
.25 
 
 
 
.12 
 
-9.83 
10.06 
-0.32 
-0.66 
 
-9.85 
9.55 
-0.72 
 
-0.85 
 
6.58 
6.82 
0.27 
0.39 
 
6.61 
6.85 
0.39 
 
0.40 
 
-0.24 
0.23 
-0.18 
-0.27 
 
-0.24 
0.22 
-0.29 
 
-0.34 
 
-1.49 
1.47 
-1.17 
-1.68 
 
-1.49 
1.39 
-1.83 
 
-2.11 
 
.15 
.15 
.25 
.10 
 
.15 
.17 
.08 
 
.04 
Note. Regression model using Stepwise method. R2 non-adjusted. MAS: Metacognition 
Assessment Scale; WAI: Working Alliance Inventory. Condition: Standard General 
Psychiatric Management vs Individualized (using the Motive-Oriented Therapeutic 
Relationship Component) General Psychiatric Management.  
 
 
